AGP Limited (PSX: AGP)

Market Cap	28.42B
Revenue (ttm)	21.24B
Net Income (ttm)	1.85B
Shares Out	280.00M
EPS (ttm)	6.61
PE Ratio	15.36
Forward PE	n/a
Dividend	2.50 (2.46%)
Ex-Dividend Date	n/a

Volume	151,371
Open	98.00
Previous Close	98.57
Day's Range	97.06 - 104.00
52-Week Range	46.00 - 111.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products under licensing arrangements in Pakistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, a...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 1,574
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2023, AGP Limited's revenue was 18.74 billion, an increase of 29.63% compared to the previous year's 14.46 billion. Earnings were 1.57 billion, a decrease of -0.31%.